Revolution Medicines Announces FDA Breakthrough Therapy Designation for Zoldonrasib
Go back to Revolution Medicines Announces FDA Breakthrough Therapy Designation for Zoldonrasib| (NASDAQ: RVMD) | Delayed: 216.00 +4.00 (1.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $212.00 | 52 Week High | $ | |||
| Open | $209.15 | 52 Week Low | $ | |||
| Day High | $216.72 | P/E | N/A | |||
| Day Low | $209.09 | EPS | $ | |||
| Volume | 1,650,658 | |||||
